Invitation: Roche Virtual Event – Key ophthalmology data presented at the Angiogenesis 2023 Meeting

   We are pleased to invite investors and analysts to participate in our virtual event onMonday, 13February 2023, highlighting Roche data presented at the virtual Angiogenesis, Exudation, and Degeneration 2023 Meeting, from 10th to 11th February. 16:30 – 18:00 CET / 15:30– 17:00 GMT10:30 – 12:00pm EST / 7:30 –9:00 am PST  The webinar will start with a presentation, followed by a Q&A session (live access to the speakers). The slides will be available for download at 15:30 CET on the day of the event.>click here Access to virtual event (pre-registration required)Please pre-register for our webinarhere*.  Should you be unable to register for the webinar due to your company IT policy, please send an e-mail [e-mail].  A replay of the webcast will be available via>ir.roche.com *privacy notice   Best regards,  Bruno EschliHead of Investor Relations   Loren KalmHead of Investor Relations, North AmericaRoche Investor Relations Dr. BrunoEschliPhone: [phone]e-mail:[e-mail] Dr. SabineBorngr äberPhone: [phone]e-mail:[e-mail] Dr. BirgitMasjostPhone: [phone]e-mail:[e-mail] Dr. Gerard TobinPhone: [phone]e-mail:[e-mail]  Investor Relations North America Loren KalmPhone: [phone]e-mail:[e-mail]  

Source: Roche Investor Update - January 23, 2023 Category: Pharmaceuticals Source Type: news